CRDF Logo

Cardiff Oncology, Inc. (CRDF) 

NASDAQ
Market Cap
$163.63M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
143 of 963
Rank in Industry
99 of 552

Largest Insider Buys in Sector

CRDF Stock Price History Chart

CRDF Stock Performance

About Cardiff Oncology, Inc.

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Insider Activity of Cardiff Oncology, Inc.

Over the last 12 months, insiders at Cardiff Oncology, Inc. have bought $981,299 and sold $0 worth of Cardiff Oncology, Inc. stock.

On average, over the past 5 years, insiders at Cardiff Oncology, Inc. have bought $720,060 and sold $657,020 worth of stock each year.

Highest buying activity among insiders over the last 12 months: PACE GARY W (director) — $3.93M.

The last purchase of 361,615 shares for transaction amount of $940,199 was made by PACE GARY W (director) on 2024‑12‑11.

List of Insider Buy and Sell Transactions, Cardiff Oncology, Inc.

2024-12-11Purchasedirector
361,615
0.5003%
$2.60$940,199+23.08%
2023-12-19Purchasedirector
30,000
0.0671%
$1.37$41,100+88.32%
2022-11-25PurchaseChief Executive Officer
10,000
0.0236%
$1.43$14,300+14.39%
2022-09-19Purchasedirector
15,000
0.0327%
$1.64$24,525-7.51%
2022-09-16PurchaseChief Financial Officer
30,000
0.0682%
$1.56$46,710+1.27%
2022-09-16Purchasedirector
13,000
0.0296%
$1.56$20,233+1.27%
2022-09-15Purchasedirector
150,000
0.3544%
$1.71$256,500-4.49%
2022-09-15Purchasedirector
10,000
0.0237%
$1.72$17,168-4.49%
2021-09-21Purchasedirector
30,000
0.0764%
$6.75$202,500-58.36%
2021-09-10PurchaseChief Financial Officer
30,000
0.0779%
$6.47$194,000-54.92%
2021-03-26Purchasedirector
2,900
0.0081%
$10.32$29,933-37.55%
2021-03-23Purchasedirector
10,000
0.0273%
$10.23$102,300-37.74%
2021-03-23Purchasedirector
2,370
0.0066%
$10.42$24,689-37.74%
2021-03-23PurchaseChief Executive Officer
965
0.0027%
$10.34$9,980-37.74%
2021-03-23PurchaseExec. VP and COO
960
0.0026%
$10.31$9,898-37.74%
2021-03-22Purchasedirector
3,000
0.0083%
$10.95$32,850-40.92%
2021-03-19Purchasedirector
4,000
0.0101%
$10.82$43,271-45.21%
2021-03-18Purchasedirector
3,000
0.0083%
$10.55$31,660-38.95%
2021-03-04Purchasedirector
1,500
0.0041%
$9.27$13,898-29.09%
2020-11-23SaleExec. VP and COO
35,321
0.147%
$18.60$657,020-57.83%

Insider Historical Profitability

94.51%
PACE GARY Wdirector
1059376
2.0718%
$3.2090+78.54%
Hunter Robert Merrill10 percent owner
5065004
9.9054%
$3.2010
BRIDGER MANAGEMENT, LLC
2968115
5.8046%
$3.2070<0.0001%
Sheinerman Kiradirector
909090
1.7779%
$3.2010
CERRONE GABRIELdirector
719526
1.4071%
$3.2050
White Laledirector
113788
0.2225%
$3.2020+295.89%
Levine James E.Chief Financial Officer
60000
0.1173%
$3.2020<0.0001%
Tennant Stanleydirector
28839
0.0564%
$3.2061<0.0001%
Erlander MarkChief Executive Officer
24481
0.0479%
$3.2040+129.51%
Markin Rodney Sdirector
23879
0.0467%
$3.2030+180.98%
JACOB GARY Sdirector
21922
0.0429%
$3.2020+280.78%
ZANIBONI STEVECFO
21329
0.0417%
$3.2020<0.0001%
SCHUH ANTONIUSCEO
20000
0.0391%
$3.2010<0.0001%
ADAMS THOMAS PHDdirector
18875
0.0369%
$3.2012+599.3%
Armitage James Odirector
13000
0.0254%
$3.2030+185.12%
BRANCACCIO JOHN Pdirector
12260
0.024%
$3.2030+178.34%
TANNENBAUM RENEE Pdirector
10000
0.0196%
$3.2010<0.0001%
Kelemen VickiExec. VP and COO
6053
0.0118%
$3.2011<0.0001%
WELCH WILLIAM JCEO
4750
0.0093%
$3.2010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$10.26M4.31.92M+0.49%+$50,559.12<0.0001
Laurion Capital Management LP$4.96M2.08928,717+28.61%+$1.1M0.04
Millennium Management LLC$3.65M1.53683,299New+$3.65M<0.01
BlackRock$3.62M1.52677,458-5.45%-$208,430.90<0.0001
MAI Capital Management, LLC$2.94M1.23551,124+45.3%+$917,486.710.03
Marshall Wace$2.32M0.97434,582New+$2.32M<0.01
Geode Capital Management$2.32M0.97434,833+2.53%+$57,296.41<0.0001
Goldman Sachs$1.53M0.64285,874New+$1.53M<0.0001
Assenagon Asset Management S.A.$1.35M0.57252,982New+$1.35M<0.01
Blair William Co Il$919,441.000.39172,180+32.45%+$225,241.15<0.01
Eam Investors$864,562.000.36161,903New+$864,562.000.05
State Street$747,306.000.31139,9450%+$0<0.0001
Qube Research & Technologies$679,691.000.29127,283+244,675%+$679,413.32<0.01
Man Group Plc$602,117.000.25112,756New+$602,117.00<0.01
Renaissance Technologies$460,000.000.1986,100-26.03%-$161,881.53<0.01
Northern Trust$456,639.000.1985,513+19.79%+$75,438.11<0.0001
Citigroup$443,829.000.1983,114New+$443,829.00<0.0001
Susquehanna International Group$444,571.000.1983,253+265.45%+$322,920.47<0.0001
Morgan Stanley$424,129.000.1879,425+421.16%+$342,747.50<0.0001
Jane Street Capital$386,211.000.1672,324+233.46%+$270,391.49<0.0001
Hrt Financial Llc$362,000.000.1567,889New+$362,000.00<0.01
Bank of America$345,631.000.1564,725+30%+$79,763.46<0.0001
OMERS$272,874.000.1151,100New+$272,874.00<0.01
Capstone Investment Advisors$273,355.000.1151,1900%+$00.01
Point72 Asia Singapore Pte Ltd$266,423.000.1149,892New+$266,423.000.03
Callan Capital$228,269.000.142,747+37.24%+$61,944.000.02
Creative Planning$214,940.000.0940,251+57.85%+$78,770.21<0.0001
Elkhorn Partners Limited Partnership$208,000.000.0939,000-40.46%-$141,333.330.15
Simplex Trading Llc$200,000.000.0837,591New+$200,000.000.01
T. Rowe Price$195,000.000.0836,5000%+$0<0.0001
Cubist Systematic Strategies$172,423.000.0732,289New+$172,423.00<0.01
Brevan Howard Capital Management Lp$173,027.000.0732,402New+$173,027.000.01
Y Intercept Hong Kong Ltd$157,338.000.0729,464New+$157,338.000.01
American Century Investments$121,880.000.0522,824New+$121,880.00<0.0001
Two Sigma$122,644.000.0522,967-25.11%-$41,118.07<0.0001
Two Sigma Advisers LP$115,878.000.0521,700-44.64%-$93,450.00<0.0001
Integrated Wealth Concepts Llc$117,480.000.0522,000New+$117,480.00<0.01
Bank of Montreal$44,200.000.0522,100New+$44,200.00<0.0001
Hightower Advisors$96,000.000.0418,000+17.39%+$14,224.00<0.0001
Squarepoint Ops LLC$93,519.000.0417,513New+$93,519.00<0.0001
Wolverine Trading$87,934.000.0416,467New+$87,934.00<0.01
Charles Schwab$87,571.000.0416,3990%+$0<0.0001
Sherbrooke Park Advisers Llc$86,230.000.0416,148New+$86,230.000.02
Findec Wealth Services Inc$85,440.000.0416,0000%+$00.08
UNITED BANK$82,770.000.0415,500+19.23%+$13,350.000.01
Royal Bank of Canada$80,000.000.0315,000+3,118.88%+$77,514.67<0.0001
Gladstone Institutional Advisory Llc$80,100.000.0315,0000%+$00.01
Marathon Trading Investment Management Llc$80,100.000.0315,000New+$80,100.000.02
Atom Investors Lp$81,691.000.0315,298-15.11%-$14,535.420.01
Dimensional Fund Advisors$75,860.000.0314,2060%+$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.